{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:09:09Z","timestamp":1761491349223,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["201442014A, 201442071A, 17929553"],"award-info":[{"award-number":["201442014A, 201442071A, 17929553"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26461275, JP18H02742","JP20K16604"],"award-info":[{"award-number":["JP26461275, JP18H02742","JP20K16604"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The research on the Nervous and Mental Disorders and Research committee for Charcot\u2013Marie\u2013Tooth Disease, Neuropathy, and Applying health and Technology of Ministry of health, Welfare and Labour, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1038\/s10038-021-01005-w","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:03:25Z","timestamp":1642118605000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments"],"prefix":"10.1038","volume":"67","author":[{"given":"Takaki","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-4900","authenticated-orcid":false,"given":"Eisuke","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-3686","authenticated-orcid":false,"given":"Masaaki","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-7997","authenticated-orcid":false,"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Sanpei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-7309","authenticated-orcid":false,"given":"Hiroyuki","family":"Ishiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-4765","authenticated-orcid":false,"given":"Jun","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5602-5686","authenticated-orcid":false,"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C. A peculiar form of peripheral neuropathy; familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408\u201327.","journal-title":"Brain"},{"key":"1005_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-018-1931-5","volume":"12","author":"H Yamamoto","year":"2018","unstructured":"Yamamoto H, Hashimoto T, Kawamura S, Kawamura S, Hiroe M, Yamashita T, et al. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. J Med Case Rep. 2018;12:370.","journal-title":"J Med Case Rep"},{"key":"1005_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon B, Ikeda S, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.","journal-title":"Orphanet J Rare Dis"},{"key":"1005_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41431-019-0337-1","volume":"27","author":"C Lahuerta Pueyo","year":"2019","unstructured":"Lahuerta Pueyo C, Aibar Arregui M\u00c1, Gracia Gutierrez A, Bueno Juana E, Menao Guill\u00e9n S. Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data. Eur J Hum Genet. 2019;27:783\u201391.","journal-title":"Eur J Hum Genet"},{"key":"1005_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0726-x","volume":"13","author":"Y Sekijima","year":"2018","unstructured":"Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis. 2018;13:6.","journal-title":"Orphanet J Rare Dis"},{"key":"1005_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2008.02.019","volume":"270","author":"Y Kato-Motozaki","year":"2008","unstructured":"Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, Nozaki I, et al. Epidemiology of familial amyloid polyneuropathy in Japan: identification of a novel endemic focus. J Neurol Sci. 2008;270:133\u201340.","journal-title":"J Neurol Sci"},{"key":"1005_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","volume":"62","author":"Y Ando","year":"2005","unstructured":"Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol. 2005;62:1057\u201362.","journal-title":"Arch Neurol"},{"key":"1005_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archneur.1968.00470360015001","volume":"18","author":"S Araki","year":"1968","unstructured":"Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol. 1968;18:593\u2013602.","journal-title":"Arch Neurol"},{"key":"1005_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","volume":"58","author":"S Ikeda","year":"2002","unstructured":"Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology. 2002;58:1001\u20137.","journal-title":"Neurology"},{"key":"1005_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000115139","volume":"19","author":"S Kito","year":"1980","unstructured":"Kito S, Itoga E, Kamiya K, Kishida T, Yammamura Y. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. Eur Neurol. 1980;19:141\u201351.","journal-title":"Eur Neurol"},{"issue":"Suppl 1","key":"1005_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/13506129.2003.12088566","volume":"10","author":"G Sobue","year":"2003","unstructured":"Sobue G, Hoike H, Misu K, Hattori N, Yamamoto M, Ikeda S, et al. Clinicopathologic and genetic features of early- and late-onset FAP type I (ATTR Val30Met) in Japan. Amyloid. 2003;10 Suppl 1:32\u20139.","journal-title":"Amyloid"},{"key":"1005_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","volume":"29","author":"D Adams","year":"2016","unstructured":"Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol. 2016;29:S14\u201326.","journal-title":"Curr Opin Neurol"},{"key":"1005_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.22229","volume":"45","author":"S Mathis","year":"2012","unstructured":"Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2012;45:26\u201331.","journal-title":"Muscle Nerve"},{"key":"1005_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0917-0","volume":"13","author":"M Grandis","year":"2018","unstructured":"Grandis M, Geroldi A, Gulli R, Manganelli F, Gotta F, Lamp M, et al. Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy \u201cin disguise\u201d. Orphanet J Rare Dis. 2018;13:177.","journal-title":"Orphanet J Rare Dis"},{"key":"1005_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","volume":"16","author":"M Cappellari","year":"2011","unstructured":"Cappellari M, Cavallaro T, Ferrarini M, Cabrini I, Taioli F, Ferrari S, et al. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Sys. 2011;16:119\u201329.","journal-title":"J Peripher Nerv Sys"},{"key":"1005_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2018-318839","volume":"90","author":"A Yoshimura","year":"2019","unstructured":"Yoshimura A, Yuan JH, Hashiguchi A, Ando M, Higuchi Y, Nakamura T, et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan. J Neurol Neurosurg Psychiatry. 2019;90:195\u2013202.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1005_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/13506129.2017.1301419","volume":"24","author":"D Keohane","year":"2017","unstructured":"Keohane D, Schwarts J, Gundapaneni B, Stewart M, Amass L. Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial. Amyloid. 2017;24:30\u20136.","journal-title":"Amyloid"},{"key":"1005_CR18","first-page":"219","volume":"24","author":"MD Benson","year":"2017","unstructured":"Benson MD, Dasgupta NR, Rissing SM, Smith J, Feigenbaum H. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. Amyloid. 2017;24:219\u201325.","journal-title":"Amyloid"},{"key":"1005_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379:11\u201321.","journal-title":"N Engl J Med"},{"key":"1005_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jns.12102","volume":"19","author":"A Hashiguchi","year":"2014","unstructured":"Hashiguchi A, Higuchi Y, Nomura M, Nakamura T, Arata H, Yuan J, et al. Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal sings. J Peripher Nerv Syst. 2014;19:311\u20136.","journal-title":"J Peripher Nerv Syst"},{"key":"1005_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2169\/internalmedicine.53.2843","volume":"53","author":"K Maeda","year":"2014","unstructured":"Maeda K, Idehara R, Hashiguchi A, Takashima H. A family with distal hereditary motor neuropathy and a K141Q mutation of small heat shock protein HSPB1. Intern Med. 2014;53:1655\u20138.","journal-title":"Intern Med"},{"key":"1005_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.24612","volume":"79","author":"Y Higuchi","year":"2016","unstructured":"Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, et al. Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2. Ann Neurol. 2016;79:659\u201372.","journal-title":"Ann Neurol"},{"key":"1005_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jns.12228","volume":"22","author":"M Ando","year":"2017","unstructured":"Ando M, Hashiguchi A, Okamoto Y, Yoshimura A, Hiramatsu Y, Yuan J, et al. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. J Peripher Nerv Syst. 2017;22:191\u20139.","journal-title":"J Peripher Nerv Syst"},{"key":"1005_CR24","doi-asserted-by":"publisher","first-page":"e1007503","DOI":"10.1371\/journal.pcbi.1007503","volume":"16","author":"P Derouault","year":"2020","unstructured":"Derouault P, Chauzeix J, RizzoD, Miressi F, magdelaine C, Bourthoumieu S, et al. CovCopCan: an efficient tool to detect copy number variation from amplicon sequencing data in inherited disease and cancer. PLoS Comput Biol. 2020;16:e1007503.","journal-title":"PLoS Comput Biol"},{"key":"1005_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guideline for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1005_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/brain\/103.2.259","volume":"103","author":"AE Harding","year":"1980","unstructured":"Harding AE, Thomas PK. The clinical feature of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259\u201380.","journal-title":"Brain"},{"key":"1005_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/aian.AIAN_276_18","volume":"22","author":"A Uzunkulao\u011flu","year":"2019","unstructured":"Uzunkulao\u011flu A, Afsar SI, Tepeli B. Terminal latency index, residual latency, and Median-Ulnar F-wave latency difference in Carpal tunnel syndrome. Ann Indian Acad Neurol. 2019;22:175\u20139.","journal-title":"Ann Indian Acad Neurol"},{"key":"1005_CR28","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, et al. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021;28:3556\u201383.","journal-title":"Eur J Neurol"},{"key":"1005_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","volume":"83","author":"H Koike","year":"2012","unstructured":"Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry. 2012;83:152\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1005_CR30","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","volume":"59","author":"H Koike","year":"2002","unstructured":"Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, et al. Type I (Transthyretin Met30) familial amyloid polyneuropathy in Japan. Arch Neurol. 2002;59:1771\u20136.","journal-title":"Arch Neurol"},{"key":"1005_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/13506120209072442","volume":"9","author":"N Kotani","year":"2002","unstructured":"Kotani N, Hattori T, Yamagata S, Tokuda T, Shirasawa A, Yamaguchi S, et al. Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy. Amyloid. 2002;9:31\u20134.","journal-title":"Amyloid"},{"key":"1005_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/ahg.12101","volume":"79","author":"MA Jang","year":"2015","unstructured":"Jang MA, Lee GY, Kim K, Kim JS, Lee SY, Kim HJ, et al. Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis. Ann Hum Genet. 2015;79:99\u2013107.","journal-title":"Ann Hum Genet"},{"key":"1005_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/13506120009146441","volume":"7","author":"M Yazak","year":"2000","unstructured":"Yazak M, Take Y, Katoh M, Ikeda S. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala. Amyloid. 2000;7:270\u20137.","journal-title":"Amyloid"},{"key":"1005_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/13506120309041740","volume":"10","author":"T Hattori","year":"2003","unstructured":"Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid. 2003;10:229\u201339.","journal-title":"Amyloid"},{"key":"1005_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3988\/jcn.2018.14.4.537","volume":"14","author":"K Choi","year":"2018","unstructured":"Choi K, Seok JM, Kim BJ, Choi YC, Shin HY, Sunwoo IN, et al. Characteristics of South Korean patients with hereditary transthyretin amyloidosis. J Clin Neurol. 2018;14:537\u201341.","journal-title":"J Clin Neurol"},{"key":"1005_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40119-021-00222-w","volume":"10","author":"H Koike","year":"2021","unstructured":"Koike H, Okumura T, Murohara T, Katsuno M. Multidisciplinary approaches for transthyretin amyloidosis. Cardiol Ther. 2021;10:289\u2013311.","journal-title":"Cardiol Ther"},{"key":"1005_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/13506129.2011.565524","volume":"18","author":"H Koike","year":"2011","unstructured":"Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid. 2011;18:56\u201362.","journal-title":"Amyloid"},{"key":"1005_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(94)90113-9","volume":"343","author":"Y Ando","year":"1994","unstructured":"Ando Y, Obayashi Y, Tanaka T, Tsuji T, Uchino M, Takahashi M, et al. Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction. Lancet. 1994;343:984\u20135.","journal-title":"Lancet"},{"key":"1005_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/brain\/awg012","volume":"126","author":"N Hattori","year":"2003","unstructured":"Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin- related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain. 2003;126:134\u201351.","journal-title":"Brain"},{"key":"1005_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/cge.13881","volume":"99","author":"T Taniguchi","year":"2021","unstructured":"Taniguchi T, Ando M, Okamoto Y, Yoshimra A, Higuchi Y, Hashiguchi A, et al. Genetic spectrum of Charcot\u2013Marie\u2013Tooth disease associated with myelin protein zero gene variants in Japan. Clin Genet. 2021;99:359\u201375.","journal-title":"Clin Genet"},{"key":"1005_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<573::AID-MUS4>3.0.CO;2-A","volume":"22","author":"D Simovic","year":"1999","unstructured":"Simovic D, Weinberg DH. The median nerve terminal latency index in carpal tunnel syndrome: a clinical case selection study. Muscle Nerve. 1999;22:573\u20137.","journal-title":"Muscle Nerve"},{"key":"1005_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00415-006-0261-5","volume":"254","author":"JS Bae","year":"2007","unstructured":"Bae JS, Kim BJ. Subclinical diabetic neuropathy with normal conventional electrophysiological study. J Neurol. 2007;254:53\u20139.","journal-title":"J Neurol"},{"key":"1005_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/2277-9175.187398","volume":"5","author":"B Vahdatpour","year":"2016","unstructured":"Vahdatpour B, Khosrawi S, Chatraei M. The role of median nerve terminal latency index in the diagnosis of carpal tunnel syndrome in comparison with other electrodiagnostic parameters. Adv Biomed Res. 2016;5:110.","journal-title":"Adv Biomed Res"},{"key":"1005_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/mus.25742","volume":"57","author":"FB Panosyan","year":"2018","unstructured":"Panosyan FB, Kirk CA, Marking D, Reilly MM, Scherer SS, Shy ME, et al. Carpal tunnel syndrome in inherited neuropathies: a retrospective survey. Muscle Nerve. 2018;57:388\u2013394.","journal-title":"Muscle Nerve"},{"key":"1005_CR45","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2021","unstructured":"Adams D, Ando Y, Beirao JM, Coelho T, Gertz MA, Gillmore JD, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268:2109\u201322.","journal-title":"J Neurol"},{"key":"1005_CR46","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1007\/s00415-020-09899-w","volume":"267","author":"B Vogt","year":"2020","unstructured":"Vogt B, Chahin N, Wiszniewski W, Ragole T, Karam C. Screening for genetic mutations in patients with neuropathy without definite etiology is useful. J Neurol. 2020;267:2648\u201354.","journal-title":"J Neurol"},{"key":"1005_CR47","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.26034","volume":"57","author":"HH Schmidt","year":"2018","unstructured":"Schmidt HH, Waddington-Cruz M, Botteman MF, Carter JA, Chopra AS, Hopps M, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57:829\u201337.","journal-title":"Muscle Nerve"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-021-01005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-021-01005-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-021-01005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T07:30:52Z","timestamp":1726471852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-021-01005-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1038\/s10038-021-01005-w","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"type":"print","value":"1434-5161"},{"type":"electronic","value":"1435-232X"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HT has been funded by Grants-in-Aid from the Research Committee of Ataxia, Health Labour Sciences Research Grant, the Ministry of Health, Labour and Welfare, Japan (201610002B), Japan Agency for Medical Research and Development (AMED) and Japan Society for the Promotion of Science (JSPS). YH and MA have been funded by Japan Society for the Promotion of Science (JSPS). Grant numbers of AMED are 201442014A, 201442071A, 17929553, and those of JSPS are JP18H02742, JP20K16604, JP21K15702, JP21H02842.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}